114 related articles for article (PubMed ID: 8710366)
1. Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells.
Jannot CB; Beerli RR; Mason S; Gullick WJ; Hynes NE
Oncogene; 1996 Jul; 13(2):275-82. PubMed ID: 8710366
[TBL] [Abstract][Full Text] [Related]
2. Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor.
Hyland S; Beerli RR; Barbas CF; Hynes NE; Wels W
Oncogene; 2003 Mar; 22(10):1557-67. PubMed ID: 12629519
[TBL] [Abstract][Full Text] [Related]
3. Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 overexpressing cancer cell lines.
Deshane J; Loechel F; Conry RM; Siegal GP; King CR; Curiel DT
Gene Ther; 1994 Sep; 1(5):332-7. PubMed ID: 7584099
[TBL] [Abstract][Full Text] [Related]
4. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
5. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
6. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
7. Autocrine inhibition of the epidermal growth factor receptor by intracellular expression of a single-chain antibody.
Beerli RR; Wels W; Hynes NE
Biochem Biophys Res Commun; 1994 Oct; 204(2):666-72. PubMed ID: 7980527
[TBL] [Abstract][Full Text] [Related]
8. Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.
Amann J; Kalyankrishna S; Massion PP; Ohm JE; Girard L; Shigematsu H; Peyton M; Juroske D; Huang Y; Stuart Salmon J; Kim YH; Pollack JR; Yanagisawa K; Gazdar A; Minna JD; Kurie JM; Carbone DP
Cancer Res; 2005 Jan; 65(1):226-35. PubMed ID: 15665299
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
10. Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes.
Altenschmidt U; Kahl R; Moritz D; Schnierle BS; Gerstmayer B; Wels W; Groner B
Clin Cancer Res; 1996 Jun; 2(6):1001-8. PubMed ID: 9816261
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
Kapoor GS; Kapitonov D; O'Rourke DM
Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of ErbB2 impairs ligand-dependent downregulation of epidermal growth factor receptors via a post-transcriptional mechanism.
Huang G; Chantry A; Epstein RJ
J Cell Biochem; 1999 Jul; 74(1):23-30. PubMed ID: 10381258
[TBL] [Abstract][Full Text] [Related]
13. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
14. Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3.
Chen X; Yeung TK; Wang Z
Biochem Biophys Res Commun; 2000 Nov; 277(3):757-63. PubMed ID: 11062025
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia.
Maity A; Pore N; Lee J; Solomon D; O'Rourke DM
Cancer Res; 2000 Oct; 60(20):5879-86. PubMed ID: 11059786
[TBL] [Abstract][Full Text] [Related]
16. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression.
Ahmad N; Gali H; Javed S; Agarwal R
Biochem Biophys Res Commun; 1998 Jun; 247(2):294-301. PubMed ID: 9642119
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.
Mamot C; Drummond DC; Greiser U; Hong K; Kirpotin DB; Marks JD; Park JW
Cancer Res; 2003 Jun; 63(12):3154-61. PubMed ID: 12810643
[TBL] [Abstract][Full Text] [Related]
18. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
Xian W; Rosenberg MP; DiGiovanni J
Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
[TBL] [Abstract][Full Text] [Related]
19. CD44 mediates constitutive type I receptor signaling in cervical carcinoma cells.
Wobus M; Kuns R; Wolf C; Horn LC; Köhler U; Sheyn I; Werness BA; Sherman LS
Gynecol Oncol; 2001 Nov; 83(2):227-34. PubMed ID: 11606076
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
